Before taking Paxlovid, consider these drug interactions
FDA and Health Canada recently approved Paxlovid as an oral treatment option for mild-to-moderate COVID-19 who are at high risk of progression to severe COVID-19. It is a combination drug containing nirmatrelvir/ritonavir. Nirmatrelvir works by binding to SARS-CoV-2 3CL protease to ultimately stop viral replication. Ritonavir does not have any antiviral activity against COVID-19 but increases concentrations of nirmatrelvir by decreasing its metabolism by CYP3A4 enzyme. Ritonavir is …
Before taking Paxlovid, consider these drug interactions












![Politics and fear have replaced science in U.S. pain management [PODCAST]](https://kevinmd.com/wp-content/uploads/11c2db8f-2b20-4a4d-81cc-083ae0f47d6e-190x100.jpeg)




![Safety-net dentistry restores human dignity for patients recovering from severe addiction [PODCAST]](https://kevinmd.com/wp-content/uploads/b3db3337-cf69-4a9b-ad93-f5c4c5d8d499-190x100.jpeg)



